Inipharm nets $35m Series A

Inipharm, a developer of therapies for liver and related diseases, has secured $35 million in Series A financing.

Inipharm, a developer of therapies for liver and related diseases, has secured $35 million in Series A financing. The investors were 5AM Ventures, Wu Capital, Frazier Healthcare Partners and Jubilant Biosys Limited.

Source: Press Release